Evidence map›Paper›PMID 23720740›Full record

ArticleThe Journal of biological chemistry2013

Calcium and calmodulin-dependent serine/threonine protein kinase type II (CaMKII)-mediated intramolecular opening of integrin cytoplasmic domain-associated protein-1 (ICAP-1α) negatively regulates β1 integrins.

Angélique Millon-Frémillon, Molly Brunner, Nadia Abed, Elodie Collomb, Anne-Sophie Ribba, Marc R Block, Corinne Albigès-Rizo, Daniel Bouvard

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. International journal of molecular medicine · 2024
    Article
  2. Article
  3. Breast cancer (Dove Medical Press) · 2023
    Review
  4. ICAP-1 loss impairs CD8European journal of immunology · 2022
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Integrins protect cardiomyocytes from ischemia/reperfusion injury.The Journal of clinical investigation · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Angélique Millon-FrémillonInstitut Albert Bonniot U823, INSERM, F-38042 Grenoble, France.
Molly Brunner
Nadia Abed
Elodie Collomb
Anne-Sophie Ribba
Marc R Block
Corinne Albigès-Rizo
Daniel Bouvard
Centre National de la Recherche Scientifique · FRUniversité Grenoble Alpes · FRInserm · FRInstitut pour l'avancée des biosciences · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Focal adhesion turnover during cell migration is an integrated cyclic process requiring tight regulation of integrin function. Interaction of integrin with its ligand depends on its activation state, which is regulated by the direct recruitment of proteins onto the β integrin chain cytoplasmic domain. We previously reported that ICAP-1α, a specific cytoplasmic partner of β1A integrins, limits both talin and kindlin interaction with β1 integrin, thereby restraining focal adhesion assembly. Here we provide evidence that the calcium and calmodulin-dependent serine/threonine protein kinase type II (CaMKII) is an important regulator of ICAP-1α for controlling focal adhesion dynamics. CaMKII directly phosphorylates ICAP-1α and disrupts an intramolecular interaction between the N- and the C-terminal domains of ICAP-1α, unmasking the PTB domain, thereby permitting ICAP-1α binding onto the β1 integrin tail. ICAP-1α direct interaction with the β1 integrin tail and the modulation of β1 integrin affinity state are required for down-regulating focal adhesion assembly. Our results point to a molecular mechanism for the phosphorylation-dependent control of ICAP-1α function by CaMKII, allowing the dynamic control of β1 integrin activation and cell adhesion.

Indexed as

AnimalsBenzenesulfonamidesBenzylaminesCalcium-Calmodulin-Dependent Protein Kinase Type 2Cell AdhesionCell MovementCells, CulturedCHO CellsCricetinaeCricetulusFocal AdhesionsImmunoblottingIntegrin beta1Intracellular Signaling Peptides and ProteinsMiceMice, KnockoutBenzenesulfonamidesBenzylaminesCalcium-Calmodulin-Dependent Protein Kinase Type 2ICAP-1 protein, mouseIntegrin beta1Intracellular Signaling Peptides and ProteinsKN 93Protein Kinase InhibitorsSulfonamidesThreonineAdhesionCaMKIIFocal AdhesionICAP-1IntegrinsMembrane ProteinsSignal Transduction

Identifiers

PMID23720740
PMCPMC3711292
OpenAlexW2060378313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.